Table 2. Surveillance intensity – all evaluable responses for common surveillance modalities subdivided by physician specialty^* (N=846).

These data show the variability in surveillance intensity among the three specialty groups (medical oncologists, radiation oncologists and surgeons) and within each group.

Modality	Year Postsurgery
Modality	1	2	3	4	5
Office visit
Medical oncologist	3.5 ± 1.6	3.0 ± 1.2	2.5 ± 1.2	2.3 ± 1.3	2.2 ± 1.4
Radiation oncologist	3.1 ± 1.4	2.7 ± 1.1	2.5 ± 1.5	2.2 ± 1.5	2.1 ± 1.5
Surgical oncologist	3.0 ± 1.7	2.6 ± 1.3	2.2 ± 1.2	1.9 ± 1.2	1.9 ± 1.2
P value	<0.0005	<0.0005	<0.02	<0.002	<0.02

Mammogram
Medical oncologist	1.6 ± 1.6	1.5 ± 1.8	1.4 ± 1.9	1.3 ± 1.9	1.3 ± 2.0
Radiation oncologist	1.7 ± 0.9	1.4 ± 0.9	1.2 ± 1.3	1.2 ± 1.3	1.2 ± 1.3
Surgical oncologist	1.4 ± 0.6	1.3 ± 0.5	1.1 ± 0.4	1.0 ± 0.2	1.0 ± 0.2
P value	0.399	0.336	0.195	0.090	0.098

Liver function tests
Medical oncologist	2.3 ± 2.1	1.9 ± 1.8	1.7 ± 1.7	1.6 ± 1.7	1.5 ± 1.7
Radiation oncologist	1.4 ± 1.8	1.1 ± 1.3	1.0 ± 1.3	0.9 ± 1.1	0.9 ± 1.1
Surgical oncologist	1.0 ± 1.3	0.9 ± 1.2	0.8 ± 1.0	0.7 ± 0.9	0.7 ± 1.0
P value	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001

The number in each cell is the number of times a particular modality is recommended in a particular posttreatment year, displayed as mean ± SD. This depiction of the data gives a conservative impression of the variation in practices.

NS = not significant

Table 2. Surveillance intensity – all evaluable responses for common surveillance modalities subdivided by physician specialty* (N=846).

Table 2. Surveillance intensity – all evaluable responses for common surveillance modalities subdivided by physician specialty^* (N=846).